Skip to main content

🚀 Special Offer🚀Get 25% off on your bioreagent online order (except Micelles and Nanodiscs), with the code: PROTEOSHOP25

📢 New ! Accelerate your Antibody Development with Ready-to-use Stable Cell Pools

Explore Now
Brand: ProteoGenix

Dupilumab Biosimilar – Anti-IL4R, CD124 mAb – Research Grade

Isotype:
IgG4, Kappa

$238.00

+ 238 loyalty points
Size
  • In Stock
  • Wide range of unique reagents
  • Fast worldwide delivery

Dupilumab Biosimilar - Anti-IL4R, CD124 mAb - Research Grade

Product name Dupilumab Biosimilar - Anti-IL4R, CD124 mAb - Research Grade
Source CAS 1190264-60-8
Species Homo sapiens
Purity >85%
Buffer PBS buffer PH7.5
Delivery condition Blue ice (+4°C)
Delivery Time 3-5 days if in stock; 3-5 weeks if production needed
Storage condition store at -80°C
Brand ProteoGenix
Applications ELISA,WB
Aliases /Synonyms Dupilumab,CD124,REGN668,SAR231893,IL4R, CD124,anti-IL4R, CD124
Reference PX-TA1308
Note For research use only. Not suitable for clinical or therapeutic use.
Isotype IgG4-kappa
Clonality Monoclonal Antibody
Product name Dupilumab Biosimilar - Anti-IL4R, CD124 mAb - Research Grade
Source CAS 1190264-60-8
Species Homo sapiens
Expression system Mammalian cells
Purity >85%
Buffer PBS buffer PH7.5
Delivery condition Blue ice (+4°C)
Delivery Time 3-5 days if in stock; 3-5 weeks if production needed
Storage condition store at -80°C
Brand ProteoGenix
Applications ELISA,WB,,,
Aliases /Synonyms Dupilumab,CD124,REGN668,SAR231893,IL4R, CD124,anti-IL4R, CD124
Reference PX-TA1308
Note For research use only. Not suitable for clinical or therapeutic use.
Isotype IgG4-kappa
Clonality Monoclonal Antibody

General information on Anti-IL4R/CD124[Homo sapiens] (Dupilumab) Monoclonal Antibody

Dupilumab is a human monoclonal antibody of isotype IgG4 that targets the interleukin-4 (IL-4) receptor, inhibiting the receptor signaling pathways. Dupilumab inhibits the signaling pathway of interleukins, that induce inflammatory and immunological reactions in several atopic or allergic conditions, such as eczema, allergic reaction, and rhinosinusitis.Dupilumab has been marketed under the trade name Dupixent. It has been also investigated for the treatment of diseases driven by allergic reactions or type 2 inflammation, such as pediatric atopic dermatitis, eosinophilic esophagitis, and chronic obstructive pulmonary disease.

SDS-PAGE for Dupilumab Biosimilar - Anti-IL4R, CD124 mAb

SDS-PAGE for Dupilumab Biosimilar - Anti-IL4R, CD124 mAb

Dupilumab Biosimilar - Anti-IL4R, CD124 mAb, on SDS-PAGE under reducing and non-reducing condition. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.

Dupilumab Biosimilar - Anti-IL4R, CD124 mAb binds to Interleukin-4 receptor subunit alpha(IL4R) in Indirect ELISA Assay

Dupilumab Biosimilar - Anti-IL4R, CD124 mAb binds to Interleukin-4 receptor subunit alpha(IL4R) in Indirect ELISA Assay

Immobilized Interleukin-4 receptor subunit alpha(IL4R) (cat. No.PX-P4860) at 0.5µg/mL (100µL/well) can bind to Dupilumab Biosimilar - Anti-IL4R, CD124 mAb (cat. No.PX-TA1308) in indirect ELISA with Goat Anti-Human IgG secondary antibody coupled with HRP measured by OD450

There are no reviews yet.

Be the first to review “Dupilumab Biosimilar – Anti-IL4R, CD124 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Recently viewed products

Loading recently viewed products…

Can’t find what you need?

Our catalog doesn’t cover everything — but our team does. Whether you need a custom antibody, a specific protein variant, or a bulk order, our scientists are here to help.

Contact Our Team Book a Call

Cart (0 Items)

Your cart is currently empty.

View Products